Insmed (INSM) Non-Current Assets (2010 - 2026)

Insmed (INSM) recorded quarterly Non-Current Assets of $462.7 million in Q1 2026, down 1.63% quarter-over-quarter from $470.4 million in Q4 2025, and up 15.66% on a YoY basis from $400.0 million in Q1 2025.

Insmed (INSM) Non-Current Assets (2010 - 2026) Analysis & Trends

Insmed's Non-Current Assets history runs 17 years deep, the most recent figure standing at $462.7 million for Q1 2026.

  • In Q1 2026, Non-Current Assets rose 15.66% year-over-year to $462.7 million; the TTM figure through Mar 2026 stood at $1.8 billion (up 10.11% YoY), while the FY2025 annual figure was $470.4 million, up 16.55% from the prior year.
  • Non-Current Assets was $462.7 million for Q1 2026 at Insmed, down from $470.4 million in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $470.4 million in Q4 2025 to a low of $362.7 million in Q3 2022.
  • Historically, Non-Current Assets has averaged $403.2 million across 5 years, with a median of $398.3 million in 2023.
  • Biggest YoY gain for Non-Current Assets was 107.52% in 2022; the steepest drop was 5.76% in 2022.
  • A 5-year view of Non-Current Assets shows it stood at $383.1 million in 2022, then climbed by 4.63% to $400.8 million in 2023, then rose by 0.7% to $403.6 million in 2024, then increased by 16.55% to $470.4 million in 2025, then dropped by 1.63% to $462.7 million in 2026.
  • The last three Non-Current Assets figures came in at $462.7 million (Q1 2026), $470.4 million (Q4 2025), and $428.9 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Alterity Therapeutics 762,369.55 Bn 762,369.51 Bn - 62,953.78
2 Belite Bio 55,096.00 Bn 55,096.00 Bn - 289.41 Mn
3 Quantum Biopharma 17,755.80 Bn 17,755.79 Bn - 4.56 Mn
4 Legend Biotech 3,486.00 Bn 3,485.71 Bn 242.10 Mn 486.60 Mn
5 Akari Therapeutics 1,737.42 Bn 1,737.41 Bn - 30.30 Mn
6 Evaxion A 1,551.28 Bn 1,551.26 Bn - -
7 Psyence Biomedical 227.32 Bn 227.31 Bn - 5.18 Mn
8 Vertex Pharmaceuticals 110.84 Bn 103.59 Bn 2.59 Bn 14.75 Bn
9 Abivax 91.71 Bn 91.71 Bn - 39.71 Mn
10 Insmed 19.79 Bn 18.57 Bn 258.54 Mn 462.69 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 462.69 Mn
Dec 31, 2025 470.35 Mn
Sep 30, 2025 428.93 Mn
Jun 30, 2025 398.28 Mn
Mar 31, 2025 400.04 Mn
Dec 31, 2024 403.57 Mn
Sep 30, 2024 403.13 Mn
Jun 30, 2024 391.93 Mn
Mar 31, 2024 400.37 Mn
Dec 31, 2023 400.77 Mn
Sep 30, 2023 398.30 Mn
Jun 30, 2023 386.72 Mn
Mar 31, 2023 388.65 Mn
Dec 31, 2022 383.05 Mn
Sep 30, 2022 362.65 Mn
Jun 30, 2022 378.63 Mn
Mar 31, 2022 397.18 Mn
Dec 31, 2021 406.47 Mn
Sep 30, 2021 352.79 Mn
Jun 30, 2021 191.59 Mn